InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,618.80
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.26
(
-0.73%
)
Bitcoin
62,492.91
(
0.25%
)
Post# of 53906
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dDT

Send PM Follow Ignore
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

dDT

Re: dDT post# 50166

Monday, 03/02/2015 4:23:07 PM

Monday, March 02, 2015 4:23:07 PM

Post# of 53906
Halozyme Therapeutics beats by $0.03, beats on revenue

Halozyme Therapeutics (NASDAQ:HALO): Q4 EPS of -$0.04 beats by $0.03.
Revenue of $30.4M (+143.2% Y/Y) beats by $4.81M.
Shares +4.8%.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up